Measurement of intravenously administered γ-Fe2O3 particle amount in mice tissues using vibrating sample magnetometer

Area of Science:

• Biomedical Engineering
• Materials Science
• Nanotechnology

Background:

• Iron oxide nanoparticles (IONPs) are utilized in biomedical applications.
• Understanding nanoparticle biodistribution is crucial for safety and efficacy.

Purpose of the Study:

• To quantify the tissue distribution of intravenously administered gamma iron oxide (γ-Fe2O3) nanoparticles in mice.
• To assess the influence of dosage on nanoparticle accumulation in various organs.

Main Methods:

• Preparation of γ-Fe2O3 nanoparticle dispersions (30-50nm).
• Intravenous administration of nanoparticles to mice.
• Magnetization measurements of dried tissues using a vibrating sample magnetometer.
• Reduction of background noise and diamagnetic effects for accurate quantification.

Main Results:

• Significant accumulation of γ-Fe2O3 nanoparticles was observed in the liver and spleen.
• Considerable accumulation occurred in the lungs, particularly at higher administration quantities.
• Minimal to no significant particle accumulation was detected in the kidneys and heart.

Conclusions:

• The liver and spleen are primary accumulation sites for γ-Fe2O3 nanoparticles following intravenous injection.
• Lung accumulation is dose-dependent.
• γ-Fe2O3 nanoparticles exhibit favorable biodistribution profiles with low uptake in the kidneys and heart, suggesting potential for targeted therapies.